Filtrona Scientific Services, a Filtrona PLC business, is in the process of making a number of new testing methods available from its world-leading laboratory in order to meet the updated US Food and Drug Administration (FDA) requirements to test all tobacco products against an expanded list of 93 harmful and potentially harmful constituents (HPHCs). Filtrona Scientific Services is actively working with the United Kingdom Accreditation Service (UKAS), a member of the International Laboratory Accreditation Co-operation (ILAC), to attain accreditation for its new testing methods.

This forms part of a structured plan Filtrona Scientific Services has in place to enable it to test tobacco products for all 93 compounds, specified by the FDA. 
UKAS carried out an audit in February this year for the new methods, which include tests to determine tobacco specific nitrosamines (TSNAs) in mainstream smoke and tobacco, carbonyls in mainstream smoke, selected volatile organic compounds in mainstream smoke and determination of mercury in tobacco. 
“Attaining these accreditations will help to ensure that we are able to supply data to the FDA for testing the specified 93 compounds in tobacco products,” Mike Taylor, director of scientific development at Filtrona Scientific Services commented. “This demonstrates how Filtrona Scientific Services is leading the way in developing new testing methods, and means we can continue to provide our customers with world-class testing services, so that they can take new and innovative products to market.”